Keyphrases
24S-hydroxycholesterol
11%
3-dimensional Model
19%
Action Potential
11%
Action Potential Threshold
11%
Anesthesia
11%
Axon Initial Segment
11%
Beta-blockers
19%
Channel Blocker
13%
Comatose Patients
11%
Cultured Hippocampal Neurons
17%
Dentate Granule Cells
21%
Depolarization
10%
Electroencephalogram
24%
Epilepsy
26%
Excitability
25%
Excitotoxic
12%
Fibrillation
19%
Fluorophore
12%
Functional Networks
19%
GABAA Receptor (GABAAR)
100%
GABAA Receptor Antagonists
11%
Glutamatergic
13%
Hydroxysteroid
11%
Intrinsic Networks
11%
Ketamine
19%
Level of Consciousness
19%
Memantine
22%
N-methyl-D-aspartate
11%
N-methyl-D-aspartate Receptor (NMDAR)
46%
Neuroactive Steroids
40%
Neurosteroids
41%
Pharmacodynamics
16%
Potentiation
38%
Pregnenolone Sulfate
23%
Receptor Activation
12%
Receptor Function
30%
Receptor Modulation
11%
Receptor-mediated
13%
Refractory Epilepsy
11%
Refractory States
12%
Resting-state Functional Connectivity (rs-FC)
11%
Seizure
27%
Surgical Treatment
11%
Synaptic
19%
Temporal Lobe Epilepsy
31%
Three-dimensional (3D)
12%
Tonic Current
10%
Visible Light
19%
Voltage Dependence
17%
Voltage Threshold
14%
Neuroscience
Action Potential
21%
Amygdalohippocampectomy
9%
Anticonvulsant
15%
Aspartic Acid
19%
Axon
15%
Behavior (Neuroscience)
14%
Bicuculline
15%
Brain Mapping
9%
Cell Membrane
15%
Channel Blocker
14%
Chloride Conductance
9%
Cholesterol Derivative
11%
Coma
11%
Electroconvulsive Therapy
9%
Electroencephalogram
30%
Excitability
24%
Excitatory Postsynaptic Potential
14%
GABAA Receptor
91%
Gamma-Aminobutyric Acid
40%
Glutamic Acid
12%
Group Frequency
9%
Ictal
9%
Ketamine
17%
Limbic Encephalitis
9%
Magnetic Resonance Imaging
11%
Medial Vestibular Nucleus
9%
Memantine
20%
Mesial Temporal Lobe Epilepsy
9%
Middle Temporal Gyrus
9%
Multielectrode Array
13%
N-Methyl-D-Aspartic Acid
10%
Neuroactive Steroid
44%
Neuroapoptosis
9%
Neuronal Excitability
9%
Neurosteroid
31%
NMDA Receptor
27%
Partial Epilepsy
9%
Polysomnography
9%
Positron Emission Tomography
19%
Pregnenolone Sulfate
22%
Receptor
65%
Receptor Antagonist
11%
Receptor Modulation
11%
Resting Potential
15%
Single-Photon Emission Computed Tomography
9%
Sleep Disorder
9%
Sodium Channel
9%
Temporal Lobe Epilepsy
22%
Video-EEG Monitoring
9%
Voltage-Gated Potassium Channel
9%